ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 173 filers reported holding ARIAD PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2015 | $679,000 | +3133.3% | 107,104 | +2871.8% | 0.00% | – |
Q3 2015 | $21,000 | -53.3% | 3,604 | -33.3% | 0.00% | – |
Q2 2015 | $45,000 | +200.0% | 5,406 | +200.0% | 0.00% | – |
Q1 2015 | $15,000 | +25.0% | 1,802 | 0.0% | 0.00% | – |
Q4 2014 | $12,000 | +20.0% | 1,802 | 0.0% | 0.00% | – |
Q3 2014 | $10,000 | +42.9% | 1,802 | +76.3% | 0.00% | – |
Q1 2014 | $7,000 | -99.0% | 1,022 | -97.4% | 0.00% | -100.0% |
Q3 2013 | $736,000 | +11.5% | 40,004 | +6.1% | 0.00% | 0.0% |
Q2 2013 | $660,000 | – | 37,690 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 12,850,000 | $175,916,000 | 40.51% |
Consonance Capital Management LP | 8,695,742 | $119,045,000 | 11.46% |
Tamarack Advisers, LP | 3,700,000 | $49,358,000 | 7.76% |
Opaleye Management Inc. | 1,045,000 | $14,306,000 | 7.49% |
Granite Point Capital Management, L.P. | 457,415 | $6,262,000 | 2.44% |
Redmile Group, LLC | 2,138,471 | $29,276,000 | 2.33% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 206,010 | $2,820,000 | 2.17% |
Palo Alto Investors LP | 2,587,617 | $35,424,000 | 2.06% |
PRICE MICHAEL F | 940,000 | $12,869,000 | 1.71% |
HighVista Strategies LLC | 638,086 | $8,735,000 | 1.62% |